Growth Metrics

Zentek (ZTEK) Income from Non-Controlling Interests (2021 - 2023)

Zentek recorded quarterly Income from Non-Controlling Interests of -$2.3 million in Q2 2023, down 163.35% quarter-over-quarter from $3.7 million in Q4 2022, and up 40.5% year-over-year from -$1.7 million in Q2 2022.

Zentek's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$2.3 million for Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 5.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 89,000.00
10 Zentek - - 84,434.04 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -2.35 Mn
Dec 31, 2022 3.71 Mn
Sep 30, 2022 -2.61 Mn
Jun 30, 2022 -3.95 Mn
Dec 31, 2021 1.73 Mn
Sep 30, 2021 23.04 Mn
Jun 30, 2021 1.51 Mn